287 related articles for article (PubMed ID: 6153937)
1. Lung damage from cytotoxic drugs.
Collis CH
Cancer Chemother Pharmacol; 1980; 4(1):17-27. PubMed ID: 6153937
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic drug-induced pulmonary disease: update 1980.
Weiss RB; Muggia FM
Am J Med; 1980 Feb; 68(2):259-66. PubMed ID: 6153504
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary effects of cytotoxic agents other than bleomycin.
Twohig KJ; Matthay RA
Clin Chest Med; 1990 Mar; 11(1):31-54. PubMed ID: 1691069
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic drug-induced lung disease.
Sostman HD; Matthay RA; Putman CE
Am J Med; 1977 Apr; 62(4):608-15. PubMed ID: 66869
[TBL] [Abstract][Full Text] [Related]
5. Hepatic and pancreatic damage produced by cytotoxic drugs.
Woolley PV
Cancer Treat Rev; 1983 Jun; 10(2):117-37. PubMed ID: 6223696
[No Abstract] [Full Text] [Related]
6. Immunosuppressive and cytotoxic chemotherapy: long-term complications.
Schein PS; Winokur SH
Ann Intern Med; 1975 Jan; 82(1):84-95. PubMed ID: 67817
[TBL] [Abstract][Full Text] [Related]
7. [Pulmonary toxicity of antineoplastic agents--with special reference to current findings on pulmonary toxicity of bleomycin].
Okuma K; Ota K
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1495-505. PubMed ID: 6191717
[TBL] [Abstract][Full Text] [Related]
8. Drug reactions. XXIV. Cutaneous reactions to cytostatic agents.
Levantine A; Almeyda J
Br J Dermatol; 1974 Feb; 90(2):239-42. PubMed ID: 4132051
[No Abstract] [Full Text] [Related]
9. Pulmonary toxicity of antineoplastic agents: anaesthetic and postoperative implications.
Klein DS; Wilds PR
Can Anaesth Soc J; 1983 Jul; 30(4):399-405. PubMed ID: 6347353
[TBL] [Abstract][Full Text] [Related]
10. Review: diagnosis of chemotherapy lung.
Sostman HD; Putman CE; Gamsu G
AJR Am J Roentgenol; 1981 Jan; 136(1):33-40. PubMed ID: 6161531
[TBL] [Abstract][Full Text] [Related]
11. Hypersensitivity reactions.
Weiss RB
Semin Oncol; 1992 Oct; 19(5):458-77. PubMed ID: 1384149
[TBL] [Abstract][Full Text] [Related]
12. [Hair changes in immunosuppressive therapy].
Kostanecki W; Mazurkiewicz W; Górkiewicz A; Zborzil J
Z Haut Geschlechtskr; 1971 Oct; 46(19):704-8. PubMed ID: 5137252
[No Abstract] [Full Text] [Related]
13. [Pulmonary cytotoxicity induced by bleomycin and methotrexate].
Sheĭkh ZhV; Krutskevich AO; Drebushevskiĭ NS; Shvaĭko SN; Dunaev AP; Alekseev VG
Vestn Rentgenol Radiol; 2015; (3):46-51. PubMed ID: 26302622
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary toxicity of antineoplastic drugs.
Willson JK
Cancer Treat Rep; 1978 Dec; 62(12):2003-8. PubMed ID: 87268
[TBL] [Abstract][Full Text] [Related]
15. Teratogenicity from drugs--an increasing problem.
Shepard TH
Dis Mon; 1974 Jun; ():1-32. PubMed ID: 4494537
[No Abstract] [Full Text] [Related]
16. Ambroxol and pulmonary toxicity induced by antineoplastic drugs.
Luisetti M; Peona V; Salmona M; Pagnoni AM; Villani F; Knerich R; Genghini M; Abbà L; Pozzi E
Int J Clin Pharmacol Res; 1986; 6(2):129-36. PubMed ID: 2424848
[TBL] [Abstract][Full Text] [Related]
17. Effects of immunosuppressive drugs during pregnancy.
Bermas BL; Hill JA
Arthritis Rheum; 1995 Dec; 38(12):1722-32. PubMed ID: 8849343
[No Abstract] [Full Text] [Related]
18. The problem of permanent bone marrow damage after cytotoxic drug treatment.
Lohrmann HP
Oncology; 1984; 41(3):180-4. PubMed ID: 6374556
[TBL] [Abstract][Full Text] [Related]
19. The spectrum of drug-induced pulmonary disease.
Rosenow EC
Ann Intern Med; 1972 Dec; 77(6):977-91. PubMed ID: 4118760
[No Abstract] [Full Text] [Related]
20. [Pulmonary fibrosis following treatment with cytostatics].
Kühböck S
Wien Med Wochenschr; 1976 Oct; 126(40):568-70. PubMed ID: 62459
[No Abstract] [Full Text] [Related]
[Next] [New Search]
